Delivery Order SPE2DE21D0005-SPE2D625F8HH6
- Not listed
- This is a fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a regenerative medicine company based in Canton, Massachusetts. The $1,504.00 contract is for the supply of PURAPLY MICRONIZED, 500MG, a specialized medical product used for advanced wound care. The award has an ultimate completion date of July 21, 2025. Organogenesis is a for-profit manufacturer that holds several significant federal Indefinite Delivery Vehicles (IDVs)...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $1,118.88 fixed-price delivery order with economic price adjustment to Organogenesis Inc., a leading regenerative medicine company based in Canton, Massachusetts. The order is for PURAPLY AM (2x2) 4 SQ CM, an advanced wound care product. This order is part of Organogenesis' broader federal contract vehicles, including a $49.5 million multiple-award Indefinite Delivery Contract with DLA Troop Support Medical for wound care...
- Organogenesis Inc. was awarded a $8,500 delivery order by the Defense Logistics Agency's Medical Supply Chain on July 23, 2025, for PURAPLY AM XT EF, a five-layer fenestrated advanced wound care product. The contract is structured as a fixed-price agreement with economic price adjustment provisions and is scheduled for completion by July 28, 2025. The work will be performed at Organogenesis' headquarters in Canton, Massachusetts. No set-aside designation was utilized for this award, indicating...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a leading regenerative medicine company. The contract, valued at $4,645.00, is for the supply of PURAPLY MZ 500MG, a regenerative wound care product. Organogenesis is a for-profit organization and a manufacturer of goods. The contract does not utilize any set-aside designations. This delivery order is part of a larger $49.5 million multiple-award Indefinite Delivery...
- The Defense Logistics Agency Troop Support Medical has awarded Organogenesis Inc., a leading regenerative medicine company, a $1,118.88 fixed-price delivery order contract to provide PURAPLY AM (2x2) 4 sq cm wound dressings. This order is part of Organogenesis' existing $49.5 million multiple-award Indefinite Delivery Contract (IDC) with the Defense Logistics Agency for wound care dressings, discs, and medical materials that runs through May 2026. Organogenesis is also a preeminent supplier of...
- This $8,500 fixed-price delivery order was awarded to Organogenesis Inc., a regenerative medicine company, by the Defense Logistics Agency (DLA) Troop Support Medical on September 11, 2024. The order is for the supply of PURAPLY AM XT, a wound care product, with an ultimate completion date of September 16, 2024. Organogenesis is a key supplier of advanced wound care and surgical biologics products to the U.S. government, primarily serving the Department of Defense and Department of Veterans...
- The U.S. Defense Logistics Agency Troop Support Medical has awarded Organogenesis Inc., a leading regenerative medicine company, a $1,118.88 fixed-price delivery order contract for PURAPLY AM (2x2) 4 SQ CM wound dressings. This is not a set-aside contract. Organogenesis is a for-profit manufacturer that has been awarded numerous prime federal contracts to provide wound care products, surgical implants, and tissue regeneration solutions to government agencies, including the Department of...
- The Defense Logistics Agency Troop Support Medical awarded a $1,118.88 fixed-price delivery order with economic price adjustment to Organogenesis Inc., a leading regenerative medicine company. The order is for PURAPLY AM (2x2) 4 sq cm, a wound care dressing product. Organogenesis Inc. has provided a variety of surgical implants, wound care dressings, and tissue regeneration products to federal agencies like the Department of Veterans Affairs and the Defense Logistics Agency through multiple...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a for-profit manufacturer of regenerative medical products headquartered in Canton, Massachusetts. The contract, valued at $3,420.00, is for the supply of PURAPLY MZ 500MG, a wound care product. The contract is a fixed-price with economic price adjustment and has a period of performance through March 6, 2025. This award is not associated with a set-aside designation,...
- This is a $1,118.88 fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a regenerative medicine company, to provide PURAPLY AM wound dressings. The order is part of a larger $49.5 million multiple-award indefinite delivery contract (IDC) that Organogenesis holds with DLA for wound care dressings, discs, and other medical materials through May 2026. Organogenesis also maintains Blanket Purchase Agreements valued up to $7 million...
- SPE2DE21D0005Indefinite Delivery Contract
- SPE2DE21D0005-SPE2D625F8HH6Delivery Order
The U.S. Defense Logistics Agency's Medical Supply Chain has awarded a delivery order valued at $1,274.00 to Organogenesis Inc. for the supply of PURAPLY Micronized 500mg, an advanced wound care product. The contract, awarded on July 23, 2025, with an ultimate completion date of July 28, 2025, utilizes fixed-price pricing with economic price adjustment and carries no set-aside designation. Organogenesis, a regenerative medicine company headquartered in Canton, Massachusetts, will perform the work at its Canton facility. The award represents a continuation of the company's role as a key supplier of specialized medical products to federal healthcare agencies. This delivery order is issued under one of Organogenesis's existing federal contract vehicles, positioning it within the company's broader portfolio of indefinite delivery agreements with the Defense Logistics Agency and the Department of Veterans Affairs. Organogenesis has maintained substantial indefinite delivery contracts totaling over $111 million across multiple agencies, including a $49.5 million multiple-award indefinite delivery contract with DLA Troop Support Medical. The company's PURAPLY product line, which includes PURAPLY Micronized and related formulations, is designed for advanced wound treatment and tissue regeneration, supporting critical medical care for military personnel and veterans. This delivery order exemplifies the routine, ongoing procurement of specialized wound care supplies that sustain federal healthcare operations across the Department of Defense and Veterans Affairs networks.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 7/23/25 |